The drug price short

Corporate villains are sometimes behind sudden increases in drug prices, but these unwanted surprises are often the result of a complicated and opaque healthcare system. The FT's David Crow joins Cardiff Garcia and Mary Childs to discuss in this snack-sized episode of the weekly podcast. Visit FT.com/Alphachat for show notes and links.